• Herston Imaging Research Facility (HIRF)

• Part-time (0.5 FTE), fixed-term position through to June 2028.
• FTE base salary will be in the range $120,317 - $134,892 + 17% super (HEW Level 8).
• Based at our Herston Imaging Research Facility, Brisbane.

About This Opportunity

Join Australia's National Imaging Facility (NIF), a world class collaborative network that provides open access to advanced imaging infrastructure, expertise, tools, data and analysis. This newly created national role offers the opportunity to shape and strengthen clinical trial capability across NIF's Magnetic Resonance Imaging (MRI) network. Working closely with the Human Molecular Imaging Network Clinical Trial Coordinator and reporting to the HIRF Director, you will play a pivotal role in establishing nationally consistent approaches to clinical trial engagement, governance, coordination and capability development across 14 participating nodes throughout Australia.

This is a unique opportunity for an experienced clinical trial professional to create meaningful impact through a collaborative, visionary and purpose driven national network.

Key responsibilities will include:

• Leading the development and implementation of nationally consistent clinical trial governance, coordination and capability frameworks across the NIF MRI network.
• Building and maintaining strategic relationships with researchers, clinicians, medical physicists, clinical trial cooperative groups, sponsors, CROs, research organisations and industry partners.
• Coordinating and overseeing multicentre clinical research projects, including trial start-up activities, ethics and governance processes, site activation, contracting and stakeholder engagement.
• Driving improvements in data management, central data review, imaging quality processes, image repositories, education initiatives and network-wide clinical trial capability.

Please note this position is advertised externally as National Clinical Trials Lead, MRI Network to reflect its national scope and strategic focus. Within UQ, the role is classified as Senior Principal Clinical Trials Coordinator.

About You

You are a collaborative and highly experienced clinical trials professional who is passionate about strengthening research capability and creating positive change through nationally coordinated initiatives. You thrive in complex stakeholder environments, exercise sound professional judgement, and enjoy building connections across organisations and disciplines.

You will demonstrate:

• A postgraduate qualification in health, science, clinical research or a related discipline, or an equivalent combination of relevant experience, education and training.
• Significant experience leading and/or coordinating clinical trial operations, programs or multicentre research activities within a health, research or academic environment.
• Strong knowledge of Good Clinical Practice (GCP), human research ethics, governance and Australian clinical trial regulatory requirements.
• Proven ability to build productive relationships and work effectively with researchers, clinicians, sponsors, CROs and other stakeholders.
• Excellent organisational, project management and communication skills, with the ability to manage competing priorities and work autonomously within a distributed national network.

The following would be highly regarded:

• Experience working within a CRO, sponsor organisation, clinical trial network or coordinating centre.
• Knowledge of Australian clinical trial regulatory pathways (CTN/CTA) and experience supporting trial start-up activities, including ethics, governance, contracting and site activation processes.

About UQ

As part of the UQ community, you'll have the opportunity to work alongside the brightest minds, who have joined us from all over the world, working together to create a better world. Join a community where excellence is at the core of our culture, contributions are valued and a range of benefits and rewards are available.

Enjoy up to 26 weeks paid parental and primary care leave, 17% super, 17.5% leave loading, flexible and hybrid working options, health and wellbeing programs, a heavily discounted Study for Staff program and salary packaging.

At UQ, you will be challenged, inspired and rewarded while working alongside a connected network of like-minded people who share a commitment to collaboration, innovation and excellence. This role offers significant flexibility, including hybrid working arrangements and a 0.5 FTE appointment, while providing the opportunity to make a lasting national impact across Australia's clinical imaging research landscape.

Interested?

For more information about this opportunity, please contact Prof Katie McMahon, Academic Lead - HIRF at [email protected]. For application inquiries, please reach out to the Talent Acquisition team at [email protected], stating the job reference number (below) in the subject line.

When you apply, please ensure you upload a resume and cover letter summarising how your background aligns to the 'About You' section.

Please note that applications received via email will not be accepted.

Other Information

Pre-employment checks may include verification of the right to work in Australia, qualifications, criminal history checks, and mandatory immunisations. This may also include checks relating to gender-based violence matters or other integrity and conduct requirements.

You must maintain unrestricted work rights in Australia for the duration of this appointment to apply. Employer sponsored work rights are not available for this appointment.

We're dedicated to equity, diversity and inclusion. We recognise that career pathways and opportunities differ, and encourage applications from candidates who may not meet every criterion but can demonstrate their potential relative to opportunity. We're also happy to support any accessibility needs throughout the recruitment process. Just let us know how we can help by emailing [email protected] or calling +61 7 3365 2623.

Applications close Wednesday 28 October 2026 at 11.00pm AEST (R-69439). Please note that interviews have been tentatively scheduled for 9 November 2026.